Výsledky vyhledávání

Akademický článek

Anti-Inflammatory Treatment of COVID-19 Pneumonia With Tofacitinib Alone or in Combination With Dexamethasone is Safe and Possibly Superior to Dexamethasone as a Single Agent in a Predominantly African American Cohort

Autor: Maroun E. Hayek, MD, Michael Mansour, MD, Harrison Ndetan, MPH, MD, PhD, Quentin Burkes, PharmD, Robert Corkern, MD, Ammar Dulli, MD, Reya Hayek, BS, Karim Parvez, MD, Satwinder Singh, MD

Publikováno v: Mayo Clinic Proceedings: Innovations, Quality & Outcomes, Vol 5, Iss 3, Pp 605-613 (2021)

Objective: To explore the survival benefit of tofacitinib in addition to dexamethasone in hospitalized patients treated for coronavirus disease 2019 (COVID-19)–related pneumonia. Patients and Methods: This is a single-center retrospective observati

Externí odkaz: https://doaj.org/article/8ab3a404cbd0447ba860dd43f601613a

Zobrazit plný text záznamu

Abstract TP23: Characteristics Of Patients With Acute Ischemic Stroke And Covid-19 Who Required Intensive Care Unit Admission Versus Ward-only: The Mississippi Academic Center Experience

Autor: Thuy Phuong Le, Reya Hayek, Oriana Sanchez, Hannah W Austin, Carmela San Luis, Sanjay Sarkar, Debarshi Roy, Shashank Shekhar, Christa O Nobleza

Publikováno v: Stroke. 53

Background: Coronavirus disease 2019 (COVID-19) is a viral disease that has primarily been known to cause respiratory symptoms; however, there has also been an association of COVID-19 with neurological symptoms, including acute ischemic stroke (AIS).

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::c1e380dfa105d344e24d2b90e7e0b55b
https://doi.org/10.1161/str.53.suppl_1.tp23

Zobrazit plný text záznamu

Autor: Reya Hayek, Quentin Burkes, Ammar Dulli, Harrison Ndetan, Satwinder Singh, Karim Parvez, Maroun E. Hayek, Robert Corkern, Michael Mansour

Publikováno v: Mayo Clinic Proceedings: Innovations, Quality & Outcomes
Mayo Clinic Proceedings: Innovations, Quality & Outcomes, Vol 5, Iss 3, Pp 605-613 (2021)

Objective To explore the survival benefit of tofacitinib in addition to dexamethasone in hospitalized patients treated for coronavirus disease 2019 (COVID-19)–related pneumonia. Patients and Methods This is a single-center retrospective observation

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0b87fafdae450bcc65f93b1ba7b7ee28
https://pubmed.ncbi.nlm.nih.gov/33817559

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání